<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; bipolar disorder</title>
	<atom:link href="http://annpharmacy.com/blog/tag/bipolar-disorder/feed" rel="self" type="application/rss+xml" />
	<link>http://annpharmacy.com/blog</link>
	<description>Health, Diseases, Drugs &#38; medications, Online canadian pharmacy</description>
	<lastBuildDate>Wed, 28 Jul 2010 16:32:20 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1-beta1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Lithium Builds Gray Matter In Patients with Bipolar Disorder</title>
		<link>http://annpharmacy.com/blog/main/lithium-builds-gray-matter-in-patients-with-bipolar-disorder.html</link>
		<comments>http://annpharmacy.com/blog/main/lithium-builds-gray-matter-in-patients-with-bipolar-disorder.html#comments</comments>
		<pubDate>Mon, 24 May 2010 15:26:12 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Main]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Gray Matter]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=284</guid>
		<description><![CDATA[Lithium, considered the standard therapy for bipolar disorder for at least 50 years, has been found to increase the amount of gray matter in the brains of patients with the illness.
Neuroscientists at the University of California, Los Angeles, used high-resolution, three-dimensional magnetic resonance imaging (MRI) to map the entire surface of the brain. They compared [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/main/lithium-builds-gray-matter-in-patients-with-bipolar-disorder.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seroquel (Quetiapine) and the Risk of Cerebrovascular Adverse Events</title>
		<link>http://annpharmacy.com/blog/anti-depressants/seroquel-quetiapine-and-the-risk-of-cerebrovascular-adverse-events.html</link>
		<comments>http://annpharmacy.com/blog/anti-depressants/seroquel-quetiapine-and-the-risk-of-cerebrovascular-adverse-events.html#comments</comments>
		<pubDate>Mon, 01 Mar 2010 11:15:36 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Depressants]]></category>
		<category><![CDATA[antipsychotics]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Cerebrovascular]]></category>
		<category><![CDATA[Quetiapine]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<category><![CDATA[Seroquel]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=228</guid>
		<description><![CDATA[Seroquel medication is  an approved medicine for bipolar  disorder and schizophrenia  medication. However, Seroquel drug is not approved for treatment of patients with dementia-related psychosis.  Since its approval in 1997, SEROQUEL has had over 8 million patient exposures  worldwide.
The results of a safety investigation, which  assessed the risk of [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-depressants/seroquel-quetiapine-and-the-risk-of-cerebrovascular-adverse-events.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Important Facts About Treatment With RISPERDAL (Risperidone)</title>
		<link>http://annpharmacy.com/blog/anti-depressants/important-facts-about-treatment-with-risperdal-risperidone.html</link>
		<comments>http://annpharmacy.com/blog/anti-depressants/important-facts-about-treatment-with-risperdal-risperidone.html#comments</comments>
		<pubDate>Fri, 26 Feb 2010 10:53:26 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Depressants]]></category>
		<category><![CDATA[antipsychotic medication]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Risperdal]]></category>
		<category><![CDATA[Risperidone]]></category>
		<category><![CDATA[Schizophrenia]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=218</guid>
		<description><![CDATA[The following safety information is necessary for  those who prescribes or is prescribed to take generic Risperdal as antipsychotic medication.
First of all, Risperdal (Risperidone) is not approved for  the treatment of patients with Dementia-Related Psychosis. Such elderly patients  treated with atypical antipsychotic  drugs are at an increased risk of death.
Second, Risperdal [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-depressants/important-facts-about-treatment-with-risperdal-risperidone.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ABILIFY (Aripiprazole) In Treatment Of Depression Disorder</title>
		<link>http://annpharmacy.com/blog/anti-acidity/abilify-aripiprazole-in-treatment-of-depression-disorder.html</link>
		<comments>http://annpharmacy.com/blog/anti-acidity/abilify-aripiprazole-in-treatment-of-depression-disorder.html#comments</comments>
		<pubDate>Sun, 21 Feb 2010 08:43:33 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Acidity]]></category>
		<category><![CDATA[Anti-Depressants]]></category>
		<category><![CDATA[Abilify]]></category>
		<category><![CDATA[Aripiprazole]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Schizophrenia]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=193</guid>
		<description><![CDATA[ABILIFY (Aripiprazole)  drug was developed by two companies: Otsuka Pharmaceutical Co., Ltd and  Bristol-Myers Squibb Company. In 2004 Abilify  medicine was approved in for treating schizophrenia disease and in 2008 it  was ratified as medicine for bipolar  disorder.
It has been known today that the U.S. Food and Drug  Administration (FDA) [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-acidity/abilify-aripiprazole-in-treatment-of-depression-disorder.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seroquel (Quetiapine) Is Effective In Treating Bipolar Disorder</title>
		<link>http://annpharmacy.com/blog/anti-depressants/seroquel-quetiapine-is-effective-in-treating-bipolar-disorder.html</link>
		<comments>http://annpharmacy.com/blog/anti-depressants/seroquel-quetiapine-is-effective-in-treating-bipolar-disorder.html#comments</comments>
		<pubDate>Fri, 19 Feb 2010 10:06:28 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Depressants]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Quetiapine]]></category>
		<category><![CDATA[Schizophrenia]]></category>
		<category><![CDATA[Seroquel]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=224</guid>
		<description><![CDATA[Professor Eduard Vieta, Clinical Institute of  Neuroscience, University of Barcelona,   Spain suggests  that bipolar disorder is considered to be a chronic, lifelong illness. Patients  can become depressed or manic. And it is generally agreed that maintenance  therapy is important and can give long-term relief from the relapses.
The data from [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-depressants/seroquel-quetiapine-is-effective-in-treating-bipolar-disorder.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Risperdal (Risperidone) Improves Manic Symptoms</title>
		<link>http://annpharmacy.com/blog/anti-depressants/risperdal-risperidone-improves-manic-symptoms.html</link>
		<comments>http://annpharmacy.com/blog/anti-depressants/risperdal-risperidone-improves-manic-symptoms.html#comments</comments>
		<pubDate>Wed, 17 Feb 2010 10:42:07 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Depressants]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Risperdal]]></category>
		<category><![CDATA[Risperidone]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=212</guid>
		<description><![CDATA[Risperdal drug (Risperidone) is an oral prescription  medication that has been approved in the UK for the treatment of mania in  bipolar disorder, also known as manic-depression. It causes periods of extreme  depression and mania and leads to unusual shifts in a person&#8217;s energy, mood and  ability to function. This chronic [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-depressants/risperdal-risperidone-improves-manic-symptoms.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Abilify (Aripiprazole) Medicine For Bipolar Disorder Is Allowed To Be Marketing</title>
		<link>http://annpharmacy.com/blog/anti-acidity/abilify-aripiprazole-medicine-for-bipolar-disorder-is-allowed-to-be-marketing.html</link>
		<comments>http://annpharmacy.com/blog/anti-acidity/abilify-aripiprazole-medicine-for-bipolar-disorder-is-allowed-to-be-marketing.html#comments</comments>
		<pubDate>Mon, 15 Feb 2010 15:33:54 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Acidity]]></category>
		<category><![CDATA[Anti-Depressants]]></category>
		<category><![CDATA[Abilify]]></category>
		<category><![CDATA[Aripiprazole]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Schizophrenia]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=190</guid>
		<description><![CDATA[Abilify drug was  generally approved in 2004 for treating schizophrenia  disease and this medicine was supposed to be used in treating bipolar disorder. Indeed, on  April 8, 2008, the European Commission allowed Abilify medication (Aripiprazole) to be marketed for patients with Bipolar I Disorder.
Such kind of disease as Bipolar I Disorder contains [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-acidity/abilify-aripiprazole-medicine-for-bipolar-disorder-is-allowed-to-be-marketing.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
